Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Robert Naclerio to Administration, Intranasal

This is a "connection" page, showing publications Robert Naclerio has written about Administration, Intranasal.

 
Connection Strength
 
 
 
2.373
 
  1. Clark JH, Baroody FM, Naclerio RM. A Pragmatic Approach Towards Sinonasal Diseases. J Allergy Clin Immunol Pract. 2020 05; 8(5):1556-1558.
    View in: PubMed
    Score: 0.215
  2. Baroody FM, Logothetis H, Vishwanath S, Bashir M, Detineo M, Naclerio RM. Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms. Am J Rhinol Allergy. 2013 Jan; 27(1):48-53.
    View in: PubMed
    Score: 0.131
  3. Baroody FM, Gavanescu L, Wang JH, DeTineo M, Naclerio RM. The effect of intranasal carbon dioxide on the acute response to nasal challenge with allergen. Allergy Asthma Proc. 2011 May-Jun; 32(3):206-12.
    View in: PubMed
    Score: 0.117
  4. Vishwanath S, Baroody FM, Chaaban MR, deTineo M, Lasser KH, Lasser EC, Naclerio RM. Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.
    View in: PubMed
    Score: 0.116
  5. Baroody FM, Brown D, Gavanescu L, DeTineo M, Naclerio RM. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011 Apr; 127(4):927-34.
    View in: PubMed
    Score: 0.116
  6. Luskin AT, Blaiss MS, Farrar JR, Settipane R, Hayden ML, Stoloff S, Chadwick SJ, Derebery MJ, Ettari MP, Luskin S, Naclerio R. Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis: a white paper. Allergy Asthma Proc. 2011 Mar-Apr; 32(2):168-77.
    View in: PubMed
    Score: 0.115
  7. Sharma S, Vasnani R, De Tineo M, Du G, Pinto JM, Baroody FM, Naclerio RM. Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):55-63.
    View in: PubMed
    Score: 0.114
  8. Baroody FM, Shenaq D, DeTineo M, Wang J, Naclerio RM. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009 Jun; 123(6):1342-8.
    View in: PubMed
    Score: 0.102
  9. Naclerio R. Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis. Otolaryngol Head Neck Surg. 2008 Feb; 138(2):129-39.
    View in: PubMed
    Score: 0.093
  10. Naclerio RM, Hadley JA, Stoloff S, Nelson HS. Patient and physician perspectives on the attributes of nasal allergy medications. Allergy Asthma Proc. 2007 May-Jun; 28 Suppl 1:S11-7.
    View in: PubMed
    Score: 0.089
  11. Pinto JM, Elwany S, Baroody FM, Naclerio RM. Effects of saline sprays on symptoms after endoscopic sinus surgery. Am J Rhinol. 2006 Mar-Apr; 20(2):191-6.
    View in: PubMed
    Score: 0.082
  12. Pinto JM, Assanasen P, Baroody FM, Naureckas E, Naclerio RM. Alpha-adrenoreceptor blockade with phenoxybenzamine does not affect the ability of the nose to condition air. J Appl Physiol (1985). 2005 Jul; 99(1):128-33.
    View in: PubMed
    Score: 0.076
  13. Bhatia S, Baroody FM, deTineo M, Naclerio RM. Increased nasal airflow with budesonide compared with desloratadine during the allergy season. Arch Otolaryngol Head Neck Surg. 2005 Mar; 131(3):223-8.
    View in: PubMed
    Score: 0.076
  14. Pinto JM, Assanasen P, Baroody FM, Naureckas E, Solway J, Naclerio RM. Treatment of nasal inflammation decreases the ability of subjects with asthma to condition inspired air. Am J Respir Crit Care Med. 2004 Oct 15; 170(8):863-9.
    View in: PubMed
    Score: 0.072
  15. Naclerio RM, Baroody FM, Bidani N, De Tineo M, Penney BC. A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone. Otolaryngol Head Neck Surg. 2003 Feb; 128(2):220-7.
    View in: PubMed
    Score: 0.066
  16. Kaszuba SM, Baroody FM, deTineo M, Haney L, Blair C, Naclerio RM. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med. 2001 Nov 26; 161(21):2581-7.
    View in: PubMed
    Score: 0.061
  17. Baroody FM, Cheng CC, Moylan B, deTineo M, Haney L, Reed KD, Cook CK, Westlund RE, Sengupta E, Corey JP, Togias A, Naclerio RM. Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):193-9.
    View in: PubMed
    Score: 0.057
  18. Naclerio RM. Dose-dependent effects of intranasal steroids: how relevant? Ann Allergy Asthma Immunol. 2000 Oct; 85(4):248-9.
    View in: PubMed
    Score: 0.056
  19. Assanasen P, Baroody FM, Rouadi P, Naureckas E, Solway J, Naclerio RM. Ipratropium bromide increases the ability of the nose to warm and humidify air. Am J Respir Crit Care Med. 2000 Sep; 162(3 Pt 1):1031-7.
    View in: PubMed
    Score: 0.056
  20. Jen A, Baroody F, de Tineo M, Haney L, Blair C, Naclerio R. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2000 Apr; 105(4):732-8.
    View in: PubMed
    Score: 0.054
  21. Baroody FM, Rouadi P, Driscoll PV, Bochner BS, Naclerio RM. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
    View in: PubMed
    Score: 0.047
  22. Naclerio RM, Adkinson NF, Moylan B, Baroody FM, Proud D, Kagey-Sobotka A, Lichtenstein LM, Hamilton R. Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
    View in: PubMed
    Score: 0.046
  23. Baroody FM, Driscoll PV, Moylan B, Fleming L, Shilstone J, Naclerio RM. Duration of action of intranasal atropine on methacholine-induced nasal secretions. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):321-3.
    View in: PubMed
    Score: 0.041
  24. Naclerio RM. Local nasal immunotherapy. Has the time come? Am J Respir Crit Care Med. 1995 Aug; 152(2):425-6.
    View in: PubMed
    Score: 0.039
  25. Naclerio RM, Baroody FM. In vivo human models for the study of anticholinergic drugs. J Allergy Clin Immunol. 1995 May; 95(5 Pt 2):1069-79.
    View in: PubMed
    Score: 0.039
  26. Brown K, Lane J, Silva MP, DeTineo M, Naclerio RM, Baroody FM. A pilot study of the effects of intranasal budesonide delivered by NasoNebĀ® on patients with perennial allergic rhinitis. Int Forum Allergy Rhinol. 2014 Jan; 4(1):43-8.
    View in: PubMed
    Score: 0.035
  27. Naclerio RM, Adkinson NF, Creticos PS, Baroody FM, Hamilton RG, Norman PS. Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol. 1993 Nov; 92(5):717-21.
    View in: PubMed
    Score: 0.035
  28. Baroody FM, Cruz AA, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol. 1992 Sep; 90(3 Pt 1):373-6.
    View in: PubMed
    Score: 0.032
  29. Cruz AA, Togias AG, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Local application of atropine attenuates the upper airway reaction to cold, dry air. Am Rev Respir Dis. 1992 Aug; 146(2):340-6.
    View in: PubMed
    Score: 0.032
  30. Sivam A, Jeswani S, Reder L, Wang J, DeTineo M, Taxy J, Baroody FM, Naclerio RM, Pinto JM. Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010 Jul-Aug; 24(4):286-90.
    View in: PubMed
    Score: 0.028
  31. Togias AG, Proud D, Kagey-Sobotka A, Freidhoff L, Lichtenstein LM, Naclerio RM. In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease. Ann Allergy. 1989 Nov; 63(5):465-9.
    View in: PubMed
    Score: 0.026
  32. Pipkorn U, Proud D, Lichtenstein LM, Schleimer RP, Peters SP, Adkinson NF, Kagey-Sobotka A, Norman PS, Naclerio RM. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987 Oct; 80(4):957-61.
    View in: PubMed
    Score: 0.023
  33. Kaiser HB, Naclerio RM, Given J, Toler TN, Ellsworth A, Philpot EE. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007 Jun; 119(6):1430-7.
    View in: PubMed
    Score: 0.022
  34. Naclerio RM, Meier HL, Kagey-Sobotka A, Norman PS, Lichtenstein LM. In vivo model for the evaluation of topical antiallergic medications. Arch Otolaryngol. 1984 Jan; 110(1):25-7.
    View in: PubMed
    Score: 0.018
  35. Bousquet J, Van Cauwenberge P, Bachert C, Canonica GW, Demoly P, Durham SR, Fokkens W, Lockey R, Meltzer EO, Mullol J, Naclerio RM, Price D, Simons FE, Vignola AM, Warner JO. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy. 2003 Mar; 58(3):192-7.
    View in: PubMed
    Score: 0.017
  36. Sanico AM, Philip G, Proud D, Naclerio RM, Togias A. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy. 1998 Jan; 28(1):92-100.
    View in: PubMed
    Score: 0.012
  37. Pongracic JA, Naclerio RM, Reynolds CJ, Proud D. A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin. Br J Clin Pharmacol. 1991 Mar; 31(3):287-94.
    View in: PubMed
    Score: 0.007
  38. Farr BM, Gwaltney JM, Hendley JO, Hayden FG, Naclerio RM, McBride T, Doyle WJ, Sorrentino JV, Riker DK, Proud D. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis. 1990 Nov; 162(5):1173-7.
    View in: PubMed
    Score: 0.007
  39. Proud D, Togias A, Naclerio RM, Crush SA, Norman PS, Lichtenstein LM. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov; 72(5):1678-85.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.